A Step-by-Step Guide to FDA 510(k) Submission

Entering the United States medical device market requires more than a technically sound product. Manufacturers must demonstrate regulatory compliance, provide complete and internally consistent documentation, and communicate clearly with the U.S. Food and Drug Administration (FDA). For most Class II medical devices, and some Class I and Class III devices, this process begins with a 510(k) submission.

The 510(k) pathway is intended to demonstrate that a medical device is substantially equivalent to a legally marketed device in the United States. Although the framework is well established, execution is often challenging. Manufacturers frequently encounter delays due to documentation gaps, unclear predicate comparisons, inconsistent terminology, or language issues, particularly when submissions rely on non-English source materials. These issues can result in FDA requests for additional information, extended review timelines, or Refuse to Accept decisions.

This guide explains the 510(k) submission process step by step, outlines FDA expectations, and highlights how accurate regulatory documentation and professional medical device translation can support timely clearance.

What Is an FDA 510(k)?

An FDA 510(k) is a premarket notification submitted to the FDA to demonstrate that a new medical device is as safe and effective as a legally marketed predicate device. Substantial equivalence is the foundation of the process.

To establish substantial equivalence, a manufacturer must show that the device:

  • Has the same intended use as the predicate, and
  • Has the same technological characteristics, or
  • Has different technological characteristics that do not raise new safety or effectiveness concerns.

A 510(k) clearance is not the same as FDA approval. It is a regulatory determination that allows the device to be legally marketed in the United States.

Types of FDA 510(k) Submissions

The FDA recognizes three main submission types, each suited to different regulatory situations. Selecting the correct pathway is critical, as an inappropriate choice can result in delays or rejection.

Traditional 510(k)

This is the most common pathway. It is used for new devices or significant modifications and requires full supporting documentation (administrative, technical and performance data).

Special 510(k)

This pathway is used when a manufacturer modifies its own legally marketed device and can demonstrate compliance through design controls. It is only applicable when the intended use remains unchanged.

Abbreviated 510(k)

This option relies on FDA guidance documents, recognized consensus standards, or special controls to reduce the amount of required data. While documentation may be reduced, manufacturers must still clearly demonstrate compliance.

Who Needs to Submit a 510(k)?

A 510(k) submission is required for most manufacturers and specification developers that intend to market a medical device in the U.S. This includes:

  • U.S.-based manufacturers introducing a new device
  • Foreign manufacturers exporting devices to the U.S.
  • Companies modifying a previously cleared device
  • Developers changing the intended use, materials, or core technology of a device

You will generally need a new 510(k) if a modification could affect the device’s safety or effectiveness. Examples include:

  • New patient-contacting materials
  • Software changes that alter device performance
  • New or expanded clinical indications
  • Manufacturing process changes that impact quality or performance

Minor changes may not require a new submission, but the rationale should always be documented.

Required Contents of a 510(k) Submission

The FDA expects each 510k submission to be complete, well-structured, and written in clear English. 

Core components of a 510(k) submission include:

1. Cover letter and FDA Form 3514

This identifies the applicant, device name, submission type, and regulatory contact.

2. Device description

A detailed explanation of design, materials, components, operating principles, and technological characteristics. This section must align with labeling and test reports.

3. Indications for use

A precise statement of the medical purpose, target population, and clinical environment. Minor wording differences here can affect the determination of substantial equivalence.

4. Substantial equivalence comparison

A structured comparison between the subject device and predicate device that addresses intended use, technology, and performance. Tables are commonly used to support clarity.

5. Performance testing

Depending on the device, this may include:

  • Bench testing
  • Biocompatibility
  • Electrical safety and EMC testing
  • Software validation and cybersecurity
  • Animal or clinical performance data

6. Labeling and instructions for use

All labeling must be consistent, accurate, and written in FDA-compliant English. This includes user manuals, packaging labels, and warnings.

7. Translations of supporting materials

If source documents are not in English, accurate translations are required. Poor translation can create ambiguity, trigger FDA questions, and delay clearance.

Professional medical device translation services help ensure consistent terminology, regulatory compliance, and alignment across all documents.

The FDA 510(k) Submission Process

Step 1: Determine Device Classification and Applicable Regulations

Devices are classified as Class I, II, or III under Title 21 of the Code of Federal Regulations. Most 510(k) submissions apply to Class II devices.

This step defines:

  • Whether a 510(k) is required
  • Applicable special controls
  • Required testing and documentation

Step 2: Identify An Appropriate Predicate Device

The predicate must be legally marketed in the U.S. and closely aligned in intended use and technology. Selecting the right predicate is a strategic decision. Poor predicate selection is a frequent cause of FDA review delays.

Step 3: Prepare and Organize Submission Documentation

All documentation must be:

  • Complete
  • Technically accurate
  • Logically structured
  • Internally consistent

Many submissions fail at this stage due to mismatched descriptions, inconsistent terminology, or incomplete data. This risk increases when documentation is created by multiple teams or in multiple languages.

Step 4: Prepare Labeling and Supporting Documentation in FDA-Compliant English

The FDA evaluates language carefully. Ambiguous wording, literal translations, or inconsistent terminology can undermine an otherwise strong submission.

Regulatory-focused localization ensures that technical meaning, safety intent, and regulatory tone are preserved. This is especially important for global manufacturers preparing U.S. submissions from non-English source documents.

Step 5: Format and Submit Electronically

All 510(k) submissions must be filed electronically using the FDA’s eSTAR system. Submissions that do not meet formatting or administrative requirements may receive a Refuse to Accept decision before scientific review begins.

Step 6: Respond to FDA Review and Additional Information Requests

During review, the FDA may issue:

  • Interactive review questions
  • Requests for additional information
  • Deficiency letters

Clear, timely, and well-documented responses are critical. Poorly written responses or inconsistent updates can reset the review clock and extend timelines.

Step 7: Receive FDA Clearance and Maintain Regulatory Records

Once cleared, the device can be marketed in the U.S. Manufacturers must continue to maintain:

  • Design history files
  • Labeling records
  • Complaint files
  • Change control documentation

Future modifications may require a new 510(k), so ongoing documentation accuracy is essential.

Conclusion

A successful 510(k) submission depends on disciplined preparation, complete documentation, and precise communication throughout the 510(k) process. From predicate selection to labeling and post-clearance change control, accuracy and consistency directly influence FDA review outcomes. For global manufacturers, high-quality medical device translation and localization reduce regulatory risk by ensuring clarity, terminology alignment, and FDA-compliant English across all submission materials.

EC Innovations provides medical device translation and regulatory documentation localization services that support 510(k) medical device submissions. Explore our medical device translation services or contact our team to discuss your regulatory documentation requirements.

Scroll to Top